Connect with us

cannabis policy

Republican Attorneys General Sue to Block Trump’s Cannabis Rescheduling Order

Published

on

Republican Attorneys General Sue to Block Trump’s Cannabis Rescheduling Order

State attorneys general from Nebraska, Indiana and Louisiana last week filed a lawsuit challenging the Justice Department’s recent order to reschedule medical cannabis. Nebraska Examiner reports.

Nebraska AG Mike Hilgers, Louisiana AG Liz Murrill and Indiana AG Todd Rokita, all Republicans, argue in the lawsuit that the rescheduling move will make it easier to push adult legalization policies. The lawsuit also challenges the expanded production of medical cannabis and tax changes under the law the new federal regime.

AG Hilgers opposed Nebraska’s campaign to legalize medical cannabis in 2024, but about 7 in 10 voters approved the reforms. Hilgers is up for re-election this year and will face Democrat Jocelyn Brasher, a former Nebraska assistant attorney general.

“Nebraskans should be outraged that taxpayer resources are being spent to challenge the Trump administration’s medical cannabis reform on an issue overwhelmingly approved by voters at the ballot box. Mike Hilgers is … interfering with decisions that families, patients and doctors have already made clear they support.” – Brasher, in a statement

In Louisiana, lawmakers created a program to make medical cannabis accessible to patients with specific debilitating conditions, while in Indiana, cannabis is not legally available for any purpose.

Meanwhile, last December, President Trump issued an executive order calling for the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act. The Justice Department issued a follow-up order last month, officially making state-regulated medical cannabis products Schedule III. The latest order, however, does not affect other forms of cannabis, meaning that state-licensed adult-use operators are still violating federal law.

The DEA is planning hearings to consider the full rescheduling of cannabis out of Schedule I, which is supposed to be reserved for drugs with “no currently accepted medical use and a high potential for abuse.”

Continue Reading

cannabis policy

Cannabis Legalization Bill Reintroduced in the Senate 

Published

on

By

Cannabis Legalization Bill Reintroduced in the Senate 

or bill federal cannabis legalization has been reintroduced in Congress, led by Democratic Senators Cory Booker (NJ), Chuck Schumer (NY) and Ron Wyden (OR). The Cannabis Stewardship and Opportunities Act would remove cannabis entirely from the Controlled Substances Act and create a Cannabis Products Center to regulate the production, labeling, distribution, sales and other elements of the cannabis industry’s production and retail.

In a statement, Booker said, if passed, the legislation would “dismantle the unjust and outdated federal prohibition of marijuana, create a federal regulatory framework to protect public health and safety, erase past convictions for low-level cannabis offenses, and provide restorative justice to communities most harmed by decades of failed drug policy.”

The measure aims to direct the Food and Drug Administration to establish labeling standards for cannabis products, including strength, dosages, servings, place of manufacture and directions for use; create programs and funding to prevent youth cannabis use; and increase funding for comprehensive treatment of opioids, stimulants, and substance use disorders.

“The over-criminalization of cannabis has destroyed many lives, disproportionately harming communities of color. Our Cannabis Stewardship and Opportunity Act is needed and would right historical wrongs by investing in safety, research, worker rights and banking access for the industry. The movement is growing and I will not stop until federal justice is achieved for the legal people. It is long past time the government caught up.” – Schumer in one press release

The proposal would maintain federal bans on trafficking cannabis in violation of state law and create a grant program to help departments combat illegal cannabis; require the Department of Transportation to create standards for cannabis-impaired driving; direct the National Highway Traffic Safety Administration to collect data on cannabis-impaired driving, create educational materials on best practices, and conduct public service advertising campaigns; and encourage states to enact bans on open containers of cannabis.

In a statement, Wyden said the “only judicial insanity” he sees “is the continued federal prohibition of cannabis.”

“Our legislation is the most comprehensive proposal on the books to end the federal ban on cannabis while keeping public health and safety front and center,” he said in the statement. “The federal government must rise to the occasion, and our bill is the way to do that.”

Additionally, the bill would transfer federal jurisdiction over cannabis to the Alcohol and Tobacco Tax and Trade Bureau; eliminating the tax code’s restriction on cannabis businesses claiming business expense deductions and implementing an excise tax on cannabis products; establishing market competition rules intended to protect independent manufacturers, wholesalers and retailers and to prevent anti-competitive behaviour.

The measure also contains provisions to encourage cannabis research, prioritize restorative and economic justice for communities and individuals most harmed by federal prohibition and the War on Drugs, and language to strengthen workers’ rights, including eliminating unnecessary pre-employment of federal employees and random drug testing for cannabis.

The proposal is co-sponsored by Senators Michael Bennet (D-CO), John Fetterman (D-PA), Kirsten Gillibrand (D-NY), John Hickenlooper (D-CO), Ben Ray Luján (D-NM), Alex Padilla (D-CA), Gary Peters (D-MI), Tina Smith (D-MN), Raphael-MAD Keyff (D-MN), Raphael-MAD (D-MA). (D-OR), Patty Murray (D-WA), Elizabeth Warren (D-MA), and Peter Welch (D-VT).

Ganjapreneur: Providing everyday knowledge since 2014, the leading digital business magazine for cannabis industry professionals. to join our community of over 40,000 cannabis entrepreneurs.

Continue Reading

cannabis policy

Massachusetts Cannabis Legalization Repeal Effort Qualifies for November Ballot

Published

on

By

Massachusetts Cannabis Legalization Repeal Effort Qualifies for November Ballot

Massachusetts officials have confirmed that a ballot initiative seeking to overturn the state’s law legalizing adult cannabis will go before voters in November. Marijuana moment reports.

The Elections Division of the Secretary of the Commonwealth’s Office informed organizers last week that they had submitted 12,551 verified signatures during the second round of petitioning, narrowly clearing the requirement of 12,429 signatures for the Nov. 3, 2026 state election ballot. Under Massachusetts law, ballot campaigns must submit signatures in two rounds, with the Legislature given an opportunity to approve the proposed measures after the first presentation. Lawmakers declined to act on the cannabis proposal in May.

If approved by voters, the measure would repeal laws allowing regulated sales of adult-use cannabis and home cultivation, leaving the state’s legal possession and medical cannabis program intact. A coalition of cannabis business leaders, health care professionals and advocates has started a campaign opposing the proposal.

The campaign behind the repeal measure, the Coalition for a Healthy Massachusetts, previously suspended a signature gatherer after a video surfaced showing the person using fraudulent arguments while gathering signatures for the Massachusetts initiative and a similar proposal in Maine. The campaign said it has “zero tolerance” for fraudulent traffic tactics.

Cannabis advocates had opposed the Massachusetts proposal on grounds that included allegedly deceptive signature-gathering tactics, unrelated topics and an allegedly deficient official summary, but their effort was rejected by the State Voting Law Commission and the state’s Supreme Judicial Court. After last week’s decision, cannabis businesses in Massachusetts came forward another challenge until repeal.

Ganjapreneur: Providing everyday knowledge since 2014, the leading digital business magazine for cannabis industry professionals. to join our community of over 40,000 cannabis entrepreneurs.

Continue Reading

cannabis policy

Wyoming Drugs Commissioner Will Not Reschedule Cannabis Under State Law Despite Federal Reforms 

Published

on

By

Wyoming Drugs Commissioner Will Not Reschedule Cannabis Under State Law Despite Federal Reforms 

The Wyoming Attorney General’s Office said the state will not reschedule cannabis under state law, regardless federal reforms the movement of medical cannabis from Schedule I to Schedule III under the Controlled Substances Act. In a policy statement released last week, the attorney general’s office said the state has already scheduled Food and Drug Administration (FDA)-approved pharmaceutical cannabis drugs — such as Dronabinol and Cesamet — as Schedule III and Schedule II drugs, respectively, and that Epidiolex has been completely removed from the state’s drug schedule.

The ruling states that state lawmakers have not legalized cannabis for any purpose in the state or recognized any other state’s medical cannabis licenses.

“Therefore, placing marijuana subject to a state medical marijuana license in Schedule III of the Wyoming Controlled Substances Act is inconsistent with the police powers heretofore exercised by the Wyoming Legislature. – Wyoming Attorney General’s Office, “Final Decision of the Commissioner of Drug and Substance Control Regarding the Placement of FDA-Approved Drug Products Containing Marijuana and Marijuana Under State License in Schedule III of the Wyoming Substances Act,” 7/7/26

The announcement adds that during a hearing in June regarding potential state rescheduling of cannabis, eight comments were received from the Drug and Substance Abuse Commissioner. Comments were evenly split between maintaining the status quo and rescheduling cannabis in Schedule III.

The order states that the commissioner “shall appropriately schedule products approved by the (FDA) after that agency has approved the product.”

Ganjapreneur: Providing everyday knowledge since 2014, the leading digital business magazine for cannabis industry professionals. to join our community of over 40,000 cannabis entrepreneurs.

TG joined Ganjapreneur in 2014 as a news writer and began hosting the Ganjapreneur podcast in 2016. He is based in upstate New York, where he also teaches media at a local university.

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media